Literature DB >> 2878710

Differences between the effects of noradrenaline and the beta-adrenoceptor agonist BRL 28410 in brown adipose tissue and hind limb of the anaesthetized rat.

P L Thurlby, R D Ellis.   

Abstract

In mature (450-600 g) 21 degrees C-acclimated male rats, anaesthetized with urethane, blood flow (measured by the radioactive microsphere technique) to brown adipose tissue (BAT) was determined during the infusion of the beta-adrenoceptor agonist BRL 28410 or noradrenaline bitartrate at doses chosen to give similar increases in whole body oxygen uptake. Blood flow to BAT during BRL 28410 infusion was only about one third of that found during noradrenaline infusion although increases in whole body thermogenesis were similar (55 and 77% for BRL 28410 and noradrenaline, respectively). This suggests that BAT may be less involved in the thermogenic response to BRL 28410 than to noradrenaline. In a separate experiment using slightly smaller rats (350-500 g) hind limb oxygen uptake was measured in situ using a venous bypass preparation. BRL 28410, at a dose having a maximum effect on whole body thermogenesis (53% increase), had no effect on oxygen delivery to the hind limb but significantly increased oxygen extraction by 33% (p less than 0.001). In contrast, noradrenaline, also at a dose that maximally increased whole body thermogenesis, led to a 35% decrease in oxygen delivery to the hind limb and no change in oxygen extraction. For the thermogenic beta-agonist BRL 28410 the hind limb, and presumably muscular tissue in general, may be contributing to thermogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878710     DOI: 10.1139/y86-189

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  12 in total

Review 1.  The beta 3-adrenergic system and beta 3-adrenergic agonists.

Authors:  J R Arch
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

Review 2.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  New Physiological Aspects of Brown Adipose Tissue.

Authors:  Paul Trayhurn; Jonathan R S Arch
Journal:  Curr Obes Rep       Date:  2014-12

Review 4.  Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue.

Authors:  Y T Yang; M A McElligott
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

5.  Shivering and nonshivering thermogenesis in exercised cold-deacclimated rats.

Authors:  K Moriya; J Arnold; J LeBlanc
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

6.  Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.

Authors:  Y L Liu; M A Cawthorne; M J Stock
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

7.  Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.

Authors:  Y L Liu; M J Stock
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

Review 8.  Renaissance of brown adipose tissue research: integrating the old and new.

Authors:  J G Granneman
Journal:  Int J Obes Suppl       Date:  2015-08-04

Review 9.  Current concepts in the pharmacological management of obesity.

Authors:  P J Carek; L M Dickerson
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

10.  Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical beta adrenoceptor agonist.

Authors:  A A Connacher; R T Jung; P E Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.